2018 — SUGAR: Epidemiologic, Physiologic and Policy Considerations of the Sugar Epidemic

2- Dr. Kelly Brownell, Ph.D. – Keynote: “Connecting Science to Social and Policy Change: The Case of Sugar” PART 1 | PART 2 | Part 3 | PART 4

~SESSION I~

3- Dr. Barry Popkin, Ph.D. – “Global Sugar Intake Patterns and Policies” PART 1 | PART 2 | PART 3 | PART 4

4- Dr. Frank Hu, M.D., Ph.D. – “Epidemiologic Evidence, Dietary Guidelines” PART 1 | PART 2 | PART 3 | PART 4

5- Dr. Michael Goran, Ph.D. – “Effects of Early-Life Exposure to Sugars on Growth and Development” PART 1 | PART 2 | PART 3

6- Panel Discussion – All Session I Speakers & Keynote PART 1 | PART 2 | PART 3

~SESSION II~

7- Dr. Kimber Stanhope, Ph.D., M.S., R.D. – “Metabolic Effects of Fructose vs. Glucose” PART 1 | PART 2 | PART 3

8- Dr. Mark Herman, M.D. – “Fructose Metabolism and Insulin Resistance” PART 1| PART 2 | PART 3 | PART 4

9- Dr. Julie Mennella, Ph.D. – “Development of Sweet Taste Preferences: The Vulnerabilities of Childhood” PART 1 | PART 2 | PART 3

10- Dr. Cara Ebbeling, Ph.D., M.S. – “Interventions for Sweetened Beverage Consumption” PART 1 | PART 2 | PART 3 |PART 4

11- Panel Discussion – All Session II Speakers PART 1 | PART 2 | PART 3 | PART 4

~SESSION III~

12- Dr. Richard Mattes, Ph.D., M.P.H., R.D. – “Low Calorie Sweeteners and Body Weight” PART 1 | PART 2 | PART 3 | PART 4

13- Dr. Vasanti Malik, Sc.D. – “Artificial Sweeteners and Chronic Disease Risk” PART 1 | PART 2 | PART 3

14- Dr. Eran Elinav, M.D., Ph.D. – “From Personalized Nutrition to Sweeteners- The Microbiome and Diet” PART 1 | PART 2

15- Dr. Steven Gortmaker, Ph.D. – “Cost-effectiveness Analysis of Sugar Sweetened Beverage Excise Taxes” PART 1 | PART 2 | PART 3

16- Dr. Sara Bleich, Ph.D. – “Labeling on Sugar Products, Industry Response” PART 1 | PART 2 | PART 3

17- Panel Discussion – All Session III Speakers PART 1 | PART 2 | PART 3